ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCAB Hears “Impressive” Progress Reports, Including Treatment for Breast, Liver Cancer, Vaccine Studies

October 18, 1974

Assumption, Not Facts Form Base For Regulation Of Carcinogens, One Regulatory Coucil consultant Says; request for Study By NSA Denied

June 8, 1979

In Brief: Caplan Receives NSB Public Service Award

March 28, 2014

CCOP Application Now Total 180 Plus

November 26, 1982

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Tobacco Council Announces Awards

September 9, 1977